Gut Microbiota Plays Crucial Role in Colorectal Cancer Detection and Treatment

Strategic Insights -

A comprehensive review of 45 studies has highlighted the importance of gut microbiota in detecting and treating colorectal cancer, the second deadliest cancer globally. The research, conducted by Taipei Medical University, found that microbes such as Fusobacterium nucleatum, Bacteroides fragilis, and Parvimonas micra have strong diagnostic accuracy across populations. Techniques like 16S rRNA sequencing and metagenomics have revealed the links between gut microbiota and colorectal cancer.

Key Takeaways:

  • The review of 45 studies (2018-2024) highlights microbial biomarkers like Fusobacterium nucleatum, Bacteroides fragilis, and Parvimonas micra as diagnostic tools for colorectal cancer.
  • These microbial biomarkers have strong diagnostic accuracy (AUC 80%) across populations, offering a non-invasive and cost-effective alternative to colonoscopy and FIT for spotting early CRC and precancerous lesions.
  • Standardizing approaches and exploring fungi and viruses are key to unlocking microbiota's full potential in CRC prevention, diagnosis, and therapy.
  • The study was conducted by Eshita Dhar, Umashankar Upadhyay, Sherali Bomrah, and Shabbir Syed-Abdul from Taipei Medical University.
  • The research has been peer-reviewed and published in the journal Studies In Health Technology and Informatics (volume 329, pages 1145-1149).

Statistics:

  • 45 studies were reviewed to understand the role of gut microbiota in colorectal cancer detection and treatment.
  • The diagnostic accuracy of microbial biomarkers like Fusobacterium nucleatum, Bacteroides fragilis, and Parvimonas micra was found to be 80% (AUC 80%).
  • Colorectal cancer is the second deadliest cancer globally, accounting for a significant number of cancer-related deaths worldwide.
  • The study highlights the importance of standardizing approaches and exploring fungi and viruses to unlock microbiota's full potential in CRC prevention, diagnosis, and therapy.

Sources:

  • "Unraveling the Role of Gut Microbiota in Colorectal Cancer: A Global Perspectives and Biomarkers as Early Screening Tool for Colorectal Cancer" (Studies In Health Technology and Informatics, 2025;329:1145-1149).
  • NewsRx. New Findings from Taipei Medical University Describe Advances in Health Technology and Informatics (Unraveling the Role of Gut Microbiota in Colorectal Cancer: A Global Perspectives and Biomarkers as Early Screening Tool for Colorectal Cancer). Health & Medicine Week. August 29, 2025; p 427.